46 related articles for article (PubMed ID: 8970537)
1. Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases.
Andersson M; Mattsson S
Front Endocrinol (Lausanne); 2021; 12():634955. PubMed ID: 33776929
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the Importance of Applying Various Methods of Calculation in Determining the Blood-Absorbed Dose for Patients with Differentiated Thyroid Carcinoma.
Al-Shakhrah IA
J Nucl Med Technol; 2023 Dec; 51(4):296-301. PubMed ID: 37433678
[TBL] [Abstract][Full Text] [Related]
3. Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.
Taprogge J; Vergara-Gil A; Leek F; Abreu C; Vávrová L; Carnegie-Peake L; Schumann S; Eberlein U; Lassmann M; Schurrat T; Luster M; Verburg FA; Vallot D; Vija L; Courbon F; Newbold K; Bardiès M; Flux G
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3225-3234. PubMed ID: 37300572
[TBL] [Abstract][Full Text] [Related]
4. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
[TBL] [Abstract][Full Text] [Related]
5. Absorbed dose coefficients for pediatric differentiated thyroid cancer patients undergoing radioiodine therapy.
Kwon TE; Kitahara CM; Lee C
J Radiol Prot; 2024 Feb; 44(1):. PubMed ID: 38232407
[TBL] [Abstract][Full Text] [Related]
6. Out-of-Field Dose Measurement by TLD Dosimetry and Estimation of Radiation-Induced Secondary Cancer Risk of Thyroid and Breast from Head Radiotherapy.
Rahbar Yazdi S; Zare MH; Broomand MA
J Biomed Phys Eng; 2023 Oct; 13(5):403-410. PubMed ID: 37868945
[TBL] [Abstract][Full Text] [Related]
7. The EANM guideline on radioiodine therapy of benign thyroid disease.
Campennì A; Avram AM; Verburg FA; Iakovou I; Hänscheid H; de Keizer B; Petranović Ovčariček P; Giovanella L
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3324-3348. PubMed ID: 37395802
[TBL] [Abstract][Full Text] [Related]
8. Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?
Knobel M
Front Endocrinol (Lausanne); 2016; 7():48. PubMed ID: 27242669
[TBL] [Abstract][Full Text] [Related]
9. Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.
Bonnema SJ; Fast S; Hegedüs L
Endocrine; 2011 Dec; 40(3):344-53. PubMed ID: 21971931
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine treatment for non-toxic goitre.
Feldt-Rasmussen U
F1000 Med Rep; 2009 Sep; 1():. PubMed ID: 20948709
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multinodular goiter by surgery.
DeGroot LJ
J Endocrinol Invest; 2001 Nov; 24(10):820-2. PubMed ID: 11765054
[No Abstract] [Full Text] [Related]
12. Multiple cysts in the cerebral white matter: a rare complication of whole brain radiation therapy.
Brandsma D; van Helvoirt R; Taphoorn MJ
J Neurooncol; 2001 May; 53(1):51-4. PubMed ID: 11678431
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
15. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine for nontoxic multinodular goiter.
Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
